• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intensive induction in older patients with acute myeloid leukemia: an initial struggle with later rewards?

作者信息

Ofran Yishai

机构信息

Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem.

出版信息

Haematologica. 2024 May 1;109(5):1331-1333. doi: 10.3324/haematol.2023.284780.

DOI:10.3324/haematol.2023.284780
PMID:38299567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11063846/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb97/11063846/2f159bcdccf3/1091331.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb97/11063846/2f159bcdccf3/1091331.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb97/11063846/2f159bcdccf3/1091331.fig1.jpg

相似文献

1
Intensive induction in older patients with acute myeloid leukemia: an initial struggle with later rewards?老年急性髓系白血病患者的强化诱导治疗：初期艰难但后期有回报？
Haematologica. 2024 May 1;109(5):1331-1333. doi: 10.3324/haematol.2023.284780.
2
Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results.帕比司他联合强化诱导化疗治疗老年急性髓系白血病患者：I 期研究结果。
Clin Cancer Res. 2019 Aug 15;25(16):4917-4923. doi: 10.1158/1078-0432.CCR-19-0171. Epub 2019 May 31.
3
The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience.诱导治疗的反应对老年急性髓系白血病患者的治疗结果至关重要：单机构经验。
Anticancer Res. 2014 Oct;34(10):5631-6.
4
Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203.预测成人急性髓系白血病强化诱导化疗的严重毒性：SWOG癌症研究网络试验S0106和S1203的分析
Leuk Lymphoma. 2021 Jul;62(7):1774-1777. doi: 10.1080/10428194.2021.1881512. Epub 2021 Feb 9.
5
[II. Leukemia in the elderly, secondary, recurrent and refractory leukemia, chloroma].[二、老年白血病、继发性白血病、复发性白血病、难治性白血病、绿色瘤]
Internist (Berl). 1996 Jun;37(6):669-77.
6
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.≥70岁新诊断急性髓系白血病患者强化诱导化疗与基于去甲基化药物方案的对比
Hematol Oncol. 2018 Apr;36(2):495-497. doi: 10.1002/hon.2456. Epub 2017 Jun 30.
7
Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemia.70岁及以上新诊断为急性髓系白血病患者的强化化疗。
Oncol Res. 2015;22(2):85-92. doi: 10.3727/096504014X14146137738547.
8
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.阿扎胞苷联合强化诱导化疗治疗老年急性髓系白血病：白血病研究联盟 AML-AZA 试验。
Leukemia. 2016 Mar;30(3):555-61. doi: 10.1038/leu.2015.306. Epub 2015 Nov 2.
9
Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry.年龄和缓解诱导治疗急性髓系白血病：来自韩国急性髓系白血病登记处的数据分析。
PLoS One. 2021 May 7;16(5):e0251011. doi: 10.1371/journal.pone.0251011. eCollection 2021.
10
When Less Is More: Reevaluating the Role of Intensive Chemotherapy for Older Adults With Acute Myeloid Leukemia in the Modern Era.少即是多：重新评估强化化疗在现代老年急性髓系白血病患者中的作用
J Clin Oncol. 2021 Oct 1;39(28):3104-3108. doi: 10.1200/JCO.21.00960. Epub 2021 Aug 18.

本文引用的文献

1
Home time among older adults with acute myeloid leukemia by therapy intensity.老年急性髓系白血病患者按治疗强度划分的回家时间
Haematologica. 2024 May 1;109(5):1588-1592. doi: 10.3324/haematol.2023.284133.
2
Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.诊断时的年龄与 AML 患者对治疗结果的偏好：探索有意义获益的离散选择实验。
Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):942-948. doi: 10.1158/1055-9965.EPI-19-1277. Epub 2020 Mar 4.
3
Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification.
在选定的 80 岁以上急性髓系白血病患者中，强化诱导治疗是有效的：欧洲白血病网络分类中使用的核型和选定分子标志物的预后意义。
Haematologica. 2014 Feb;99(2):308-13. doi: 10.3324/haematol.2013.092072. Epub 2013 Oct 4.
4
High-dose daunorubicin in older patients with acute myeloid leukemia.老年急性髓系白血病患者使用大剂量柔红霉素治疗
N Engl J Med. 2009 Sep 24;361(13):1235-48. doi: 10.1056/NEJMoa0901409.